Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
7% hypertonic saline before ELTGOL in bronchiectasis
2020-001026-62Phase 4Active
- Sponsor
- Hospital Universitari de Girona Dr. Josep Trueta
- Start
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of hypertonic saline and isotonic saline in bronchiectasis (3 arms), sponsored by Hospital Universitari de Girona Dr. Josep Trueta. Started Oct 2021; status: active.
02
Drugs
hypertonic salineisotonic saline
03
Conditions
bronchiectasis
Beyond the preview
Go deeper on 2020-001026-62.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-001026-62.